The prolonged stimulation of T cell receptor (TCR) could drive T cell exhaustion, which could be further maintained by the interaction between PD-1 receptor present in the membrane of T cells, and PD-L1 present on the surface of cancer cells, which can be targeted by anti-PD-1 therapeutic strategies. The gene discussed is CD274; the disease is cancer.